Lupin has obtained approval from the USFDA to market a generic form of an HIV medication. The approved drug, equivalent to Symtuza tablets, positions Lupin as the exclusive first-to-file. The tablets ...

Lupin has received USFDA approval for its generic version of Symtuza, a medication for HIV. The product is estimated to have ...

The fixed-dose combination of Abacavir 60 mg/Dolutegravir 5 mg/Lamivudine 30 mg tablets for oral suspension is a once-daily ...

The US Food and Drug Administration (FDA) has approved the abbreviated new drug application (ANDA) of Lupin’s Sacubitril and ...

This product would be manufactured at the drug firm's Nagpur facility and will be supplied to low-and middle-income ... thereby significantly boosting our HIV medication portfolio," Lupin Executive ...

Lupin has received USFDA approval to market a generic HIV medication in the US market, under the PEPFAR program. The drug will be manufactured in Nagpur and supplied to low-and middle-income countries ...

This new generic medicine is designed to be a simple, once-daily treatment for children as young as three months old who ...

Mumbai: In a fresh challenge to Novartis' blockbuster heart failure drug Entresto, Indian generics maker Lupin has received ...